Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Aliza T. Ehrlich, Brigitte L. Kieffer & Emmanuel Darcq. (2019) Current strategies toward safer mu opioid receptor drugs for pain management. Expert Opinion on Therapeutic Targets 23:4, pages 315-326.
Read now
Read now
Jin Seok Ahn, Johnson Lin, Setsuro Ogawa, Chen Yuan, Tony O’Brien, Brian HC Le, Andrea M Bothwell, Hanlim Moon, Yacine Hadjiat & Abhijith Ganapathi. (2017) Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review. Journal of Pain Research 10, pages 1963-1972.
Read now
Read now
Articles from other publishers (10)
Jessie Markovits, Ondrej Blaha, Emma Zhao & David Spiegel. (2022) Effects of hypnosis versus enhanced standard of care on postoperative opioid use after total knee arthroplasty: the HYPNO-TKA randomized clinical trial. Regional Anesthesia & Pain Medicine 47:9, pages 534-540.
Crossref
Crossref
Victoria D. Powell, Jack M. Rosenberg, Avani Yaganti, Claire Garpestad, Pooja Lagisetty, Carol Shannon & Maria J. Silveira. (2021) Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain. JAMA Network Open 4:9, pages e2124152.
Crossref
Crossref
Marin Golčić, Renata Dobrila-Dintinjana, Goran Golčić & Lidija Gović-Golčić. (2018) Differences between Transdermal Fentanyl and Buprenorphine in the Elderly Hospice Patients. Pain Research and Treatment 2018, pages 1-5.
Crossref
Crossref
Mellar P. Davis, Gavril Pasternak & Bertrand Behm. (2018) Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 78:12, pages 1211-1228.
Crossref
Crossref
Yolanda Escobar Alvarez, Claudia Agamez Insignares, Monica Ahumada Olea, Olga Barajas, German Calderillo, Jenny Cecilia Calvache Guamán, Ricardo Caponero, Benjamín A Cavenago Salazar, Auro Del Giglio, Ana Rocío Pupo Araya, Ricardo Villalobos-Valencia, Andrés Yepes Pérez & Nilda Zumelzu Delgado. (2017) Cancer pain management: recommendations from a Latin-American experts panel. Future Oncology 13:27, pages 2455-2472.
Crossref
Crossref
Yakir Segev, Lior Segev, Meirav Schmidt, Ron Auslender & Ofer Lavie. (2017) Palliative care in ovarian carcinoma patients—a personalized approach of a team work: a review. Archives of Gynecology and Obstetrics 296:4, pages 691-700.
Crossref
Crossref
August S. Bassani & Daniel Banov. (2016) Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model. Pain Medicine 17:2, pages 230-238.
Crossref
Crossref
Yoshiaki Nikaido, Aya Kurosawa, Hitomi Saikawa, Satoshi Kuroiwa, Chiharu Suzuki, Nobuo Kuwabara, Hazime Hoshino, Hideaki Obata, Shigeru Saito, Tamio Saito, Hiroyuki Osada, Isao Kobayashi, Hideki Sezutsu & Shigeki Takeda. (2015) In vivo and in vitro evaluation of novel μ-opioid receptor agonist compounds. European Journal of Pharmacology 767, pages 193-200.
Crossref
Crossref
Daniel T. Barratt, Pål Klepstad, Ola Dale, Stein Kaasa & Andrew A. Somogyi. (2015) Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl. PLOS ONE 10:9, pages e0137179.
Crossref
Crossref
Manuel Heim. (2015) Noninterventional Study of Transdermal Fentanyl (Fentavera) Matrix Patches in Chronic Pain Patients: Analgesic and Quality of Life Effects. Pain Research and Treatment 2015, pages 1-9.
Crossref
Crossref